QuVa
Endo granted injunction to block blood pressure competitor
March 2, 2018Medical Communications, Sales and Marketing Endo, QuVa, Vasostrict, blood pressure, pharma, vasopressin
Generics and speciality pharma firm Endo International has revealed that it has been granted a preliminary injunction to block competitor …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
